美国总统特朗普：药品关税即将到来。

Core Viewpoint - The announcement by President Trump regarding the imminent implementation of drug tariffs indicates a significant shift in U.S. trade policy, particularly affecting the pharmaceutical industry [1] Industry Impact - The introduction of drug tariffs is expected to impact pricing strategies within the pharmaceutical sector, potentially leading to increased costs for consumers and healthcare providers [1] - Companies may need to reassess their supply chains and pricing models in response to the new tariffs, which could affect profit margins and market competitiveness [1] Company Implications - Pharmaceutical companies operating in the U.S. may face challenges in maintaining their market positions due to the added financial burden from tariffs [1] - The potential for increased regulatory scrutiny and compliance costs could further complicate operations for these companies [1]